Literature DB >> 32552307

A rationale for blocking thromboinflammation in COVID-19 with Btk inhibitors.

Phillip Lr Nicolson1, John D Welsh2, Abhishek Chauhan3, Mark R Thomas1, Mark L Kahn2, Steve P Watson1,4.   

Abstract

Entities:  

Keywords:  Btk; COVID-19; platelets; thromboinflammation

Mesh：

Substances：

Year:  2020        PMID： 32552307     DOI： 10.1080/09537104.2020.1775189

Source DB:  PubMed          Journal:  Platelets        ISSN： 0953-7104            Impact factor:   3.862


× No keyword cloud information.
  13 in total

1.  Antithrombotic Effects of Fostamatinib in Combination with Conventional Antiplatelet Drugs.

Authors:  Maan H Harbi; Christopher W Smith; Fawaz O Alenazy; Phillip L R Nicolson; Alok Tiwari; Steve P Watson; Mark R Thomas
Journal:  Int J Mol Sci       Date:  2022-06-23       Impact factor: 6.208

2.  Real-World Use of Fostamatinib in Patients with Immune Thrombocytopenia and Thrombotic Risk.

Authors:  Amit R Mehta; Aron Kefela; Charina Toste; Donald Sweet
Journal:  Acta Haematol       Date:  2021-12-14       Impact factor: 3.068

3.  Assessment of thrombotic risk during long-term treatment of immune thrombocytopenia with fostamatinib.

Authors:  Nichola Cooper; Ivy Altomare; Mark R Thomas; Phillip L R Nicolson; Steve P Watson; Vadim Markovtsov; Leslie K Todd; Esteban Masuda; James B Bussel
Journal:  Ther Adv Hematol       Date:  2021-04-30

Review 4.  Reining in BTK: Interdomain Interactions and Their Importance in the Regulatory Control of BTK.

Authors:  Lauren E Kueffer; Raji E Joseph; Amy H Andreotti
Journal:  Front Cell Dev Biol       Date:  2021-06-23

Review 5.  The Role of CLEC-2 and Its Ligands in Thromboinflammation.

Authors:  Danyang Meng; Man Luo; Beibei Liu
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

6.  Pulmonary artery thrombi are co-located with opacifications in SARS-CoV2 induced ARDS.

Authors:  Katharina Mueller-Peltzer; Tobias Krauss; Matthias Benndorf; Corinna N Lang; Fabian Bamberg; Christoph Bode; Daniel Duerschmied; Dawid L Staudacher; Viviane Zotzmann
Journal:  Respir Med       Date:  2020-09-11       Impact factor: 4.582

Review 7.  Molecular Drivers of Platelet Activation: Unraveling Novel Targets for Anti-Thrombotic and Anti-Thrombo-Inflammatory Therapy.

Authors:  Madhumita Chatterjee; Agnes Ehrenberg; Laura Mara Toska; Lisa Maria Metz; Meike Klier; Irena Krueger; Friedrich Reusswig; Margitta Elvers
Journal:  Int J Mol Sci       Date:  2020-10-24       Impact factor: 5.923

Review 8.  The interplay between inflammatory pathways and COVID-19: A critical review on pathogenesis and therapeutic options.

Authors:  Shalki Choudhary; Kajal Sharma; Om Silakari
Journal:  Microb Pathog       Date:  2020-12-02       Impact factor: 3.848

9.  Bruton tyrosine kinase inhibitors as potential therapeutic agents for COVID-19: A review.

Authors:  Zemene Demelash Kifle
Journal:  Metabol Open       Date:  2021-07-29

10.  Aberrant glycosylation of anti-SARS-CoV-2 spike IgG is a prothrombotic stimulus for platelets.

Authors:  Alexander P Bye; Willianne Hoepel; Joanne L Mitchell; Sophie Jégouic; Silvia Loureiro; Tanya Sage; Gestur Vidarsson; Jan Nouta; Manfred Wuhrer; Steven de Taeye; Marit van Gils; Neline Kriek; Nichola Cooper; Ian Jones; Jeroen den Dunnen; Jonathan M Gibbins
Journal:  Blood       Date:  2021-10-21       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.